Review summarizes predictive biomarkers for immune checkpoint inhibitor response in Merkel cell carcinoma, highlighting avenues for personalized immunotherapy.
. This review summarizes current knowledge and discusses emerging and potentially predictive biomarkers for MCC therapy with ICI.
No takes yet. Share an insight, caveat, or question.
Fojnica et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: